Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
about
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.Epithelial-mesenchymal plasticity in circulating tumor cells.Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine.Androgen receptor expression on circulating tumor cells in metastatic breast cancer.Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges.Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology.Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer.Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumour macrophages partially through interleukin 10.Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy.Unmasking molecular profiles of bladder cancer.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondMultimodal detection of PD-L1: reasonable biomarkers for immune checkpoint inhibitor
P2860
Q37702430-82073318-8AA7-4926-8314-0A49D26835CFQ38711439-80FBE568-1887-42B0-84A9-410B6C297853Q38838108-B05BC31C-037D-4141-9964-7E9391669582Q39053335-A1869193-DE61-4659-9932-112F095A0D87Q39132961-67D7A5B0-5FAA-42F3-AE4B-FD72E308E388Q42366191-51D9DFAC-27E8-484E-9983-A969288D1685Q42700740-BF079748-2263-4900-8D45-C211333642C1Q45891469-DE90BC48-0BD5-435D-9AE8-41B01DD24B28Q47110464-9D8EBFE0-4987-468E-A265-E3C113A7299EQ47153925-5AB61987-DCA5-4D3A-BEBF-E1EA6C9DBED1Q48227716-C49E6937-FD19-4C14-B8C4-A9D3B873ECD9Q49220712-7CC35798-1906-4740-8BF8-CAFBE617CDF2Q49380125-CA39A2C6-0181-407A-8953-DD9DAE3B4B55Q50129978-C1D77AD6-D328-4404-9DCE-5038474B8AD1Q51005809-675CB3FC-4289-4949-9A70-DB817D674ED1Q53097632-E0B56905-9DCB-4BF1-BABE-A48122F4F3A7Q55071620-DBFFEEA3-501B-4035-A061-74AD3A273813Q55427566-0A3AE8B8-5FD9-4407-8F88-A8E65E49B0EFQ56891609-698B6458-AC49-4B73-A297-E1B27FD3FCF5Q57494139-09442248-0507-47F8-984E-E1FCEDE2D47D
P2860
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@ast
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@en
type
label
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@ast
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@en
prefLabel
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@ast
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@en
P2093
P2860
P1433
P1476
Programmed death-ligand 1 (PD- ...... static bladder cancer patients
@en
P2093
Adam Jendrisak
Archana Anantharaman
Gayatri Premasekharan
Jeffrey Hough
Jessica Louw
Karla Lindquist
Lyndsey Dugan
Matthew Edwards
Pamela L Paris
P2860
P2888
P356
10.1186/S12885-016-2758-3
P407
P577
2016-09-22T00:00:00Z
P6179
1004386464